<SEC-DOCUMENT>0000919574-26-002927-index.html : 20260513
<SEC-HEADER>0000919574-26-002927.hdr.sgml : 20260513
<ACCEPTANCE-DATETIME>20260513091401
ACCESSION NUMBER:		0000919574-26-002927
CONFORMED SUBMISSION TYPE:	SCHEDULE 13G
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20260513
DATE AS OF CHANGE:		20260513

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Forte Biosciences, Inc.
		CENTRAL INDEX KEY:			0001419041
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				261243872
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-89959
		FILM NUMBER:		26971245

	BUSINESS ADDRESS:	
		STREET 1:		3060 PEGASUS PARK DRIVE
		STREET 2:		BUILDING 6
		CITY:			DALLAS
		STATE:			TX
		ZIP:			75247
		BUSINESS PHONE:		(310) 618-6994

	MAIL ADDRESS:	
		STREET 1:		3060 PEGASUS PARK DRIVE
		STREET 2:		BUILDING 6
		CITY:			DALLAS
		STATE:			TX
		ZIP:			75247

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Tocagen Inc
		DATE OF NAME CHANGE:	20071120

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Adage Capital Management, L.P.
		CENTRAL INDEX KEY:			0001535978
		ORGANIZATION NAME:           	
		EIN:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G

	BUSINESS ADDRESS:	
		STREET 1:		200 CLARENDON STREET, 52ND FLOOR
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02116
		BUSINESS PHONE:		617-867-2800

	MAIL ADDRESS:	
		STREET 1:		200 CLARENDON STREET, 52ND FLOOR
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02116
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13G
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
Document 1 - file: primary_doc.html

Document 1 - RAW XML: primary_doc.xml

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d12144695_ex99-1.htm
<DESCRIPTION>JOINT FILING STATEMENT
<TEXT>
Document 2 - file: d12144695_ex99-1.htm

</DOCUMENT>
</SEC-DOCUMENT>